Jonathan Hahn active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Tuteur SA | Director/Board Member | 31/12/2012 | - |
| President | 31/12/2012 | - | |
| Corporate Officer/Principal | 31/12/2012 | - | |
| Tuteur SACIFIA | Director/Board Member | 31/12/2012 | - |
| President | 31/12/2012 | - |
Career history of Jonathan Hahn
Former positions of Jonathan Hahn
| Companies | Position | Start | End |
|---|---|---|---|
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | - | - |
| KAMADA LTD. | Director/Board Member | 24/03/2010 | - |
Training of Jonathan Hahn
| University of San Andres | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Statistics
International
| Argentina | 4 |
| United States | 3 |
| Israel | 2 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| President | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| KAMADA LTD. | Health Technology |
| Private companies | 3 |
|---|---|
| Tuteur SA | |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
| Tuteur SACIFIA |
- Stock Market
- Insiders
- Jonathan Hahn
- Experience
